Table 1.
Demographic data of patient cohort.
Overall | |
---|---|
(N = 117) | |
DFS (months) | |
Mean (SD) | 51.7 (27.9) |
Median [Min, Max] | 50.7 [2.40, 115] |
IQR | [25.9 - 73.0] |
OS (months) | |
Mean (SD) | 58.5 (24.7) |
Median [Min, Max] | 59.1 [9.20, 115] |
IQR | [38.9–76.7] |
sex | |
Female | 46 (39.3%) |
Male | 71 (60.7%) |
T | |
2 | 10 (8.5%) |
3 | 70 (59.8%) |
4 | 37 (31.6%) |
N | |
1 | 83 (70.9%) |
2 | 34 (29.1%) |
Age (years) | |
Mean (SD) | 59.2 (11.2) |
Median [Min, Max] | 61.0 [26.0, 79.0] |
IQR | [52.0–67.0] |
LNC | |
Mean (SD) | 21.3 (11.0) |
Median [Min, Max] | 19.0 [5.00, 73.0] |
IQR | [14.0–25.0] |
PLN | |
Mean (SD) | 3.05 (2.49) |
Median [Min, Max] | 2.00 [1.00, 13.0] |
IQR | [1.00–4.00] |
LVI | |
No | 49 (41.9%) |
Yes | 68 (58.1%) |
Differentiation | |
Moderate to well | 99 (84.6%) |
Poor | 16 (13.7%) |
Missing | 2 (1.7%) |
MSI status | |
MSI | 5 (4.3%) |
MSS | 30 (25.6%) |
Missing | 82 (70.1%) |
LNC lymph node count, PLN positive lymph nodes, LVI lymphovascular invasion.